Pfizer stock: buy or sell
Updated on:
Apr 22nd, 2021
2
Pfizer stock brief
- Pfizer stock moved up 1.28% to close at $39.53 on the stock market today, after 10 consecutive sessions in green.
- Pfizer is presenting its earnings report next Tuesday
- The price is currently over the upper Bollinger band, which is usually an indicator of a short-term correction
- On April 15, it broke out above $37.42, a resistance not crossed since last January.
- Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide.
Should I buy Pfizer stock?
All successful traders recommend adhering to a trading strategy and not make decisions based on subjective opinions, rumors or feelings. Trading strategies are meant for helping you in the decision process of what stocks to pick and when is the best moment to buy them. At Stocks2.com, we like to use very simple but trusted and powerful trend following trading strategies. Simple things usually work the best
Is $PFE stock a buy?
Currently, Pfizer stock doesn't match any of these trading strategies, so our recommendation is not to buy now. This doesn't mean we expect a selloff for $PFE in coming sessions, or that it may not rise higher. Simply, it doesn't match our recommended trading systems
Should I sell Pfizer stock?
Knowing when to sell a stock is even more difficult than knowing when to buy it. Much like when we have to buy shares, choosing when is appropiate to sell is not a whimsical decision, and we must follow our own trading strategy. Our trading system selects very simple setups to guide us on when is a good time to sell our shares. Be aware that these setups should not be used for shorting Pfizer stock
A golden rule is that you should never mantain an operation that produces losses greater than those expected at the time of purchase. The moment to sell your stock must always be ruled by the stop-loss (automatic or manual)
Is it time to sell Pfizer stock?
Currently, Pfizer stock doesn't match any of our preferred sell setups, so if you own Pfizer stock and your operation is in profit probably is not time to sell now
Pfizer ratings
In the last month, 4 ratings were published for Pfizer
| Brokerage firm | Rating |
|---|---|
| Mar 23rd, 2021 | |
| Berenberg Bank | Neutral |
| Mar 26th, 2021 | |
| SVB Leerink | |
| Apr 1st, 2021 | |
| SVB Leerink | |
| Apr 7th, 2021 | |
| Royal Bank of Canada | |
Pfizer stock analysis
In late March, the price broke out above the previous top at $35.78 on the downtrend started in December 2020. Since then, the price action resulted in a 10.48% gain.
SMAs overview
Supports and resistances
The current resistance levels are:
The current supports are:
Bollinger bands
When the price moves out of the band (above the upper line or below the lower line) it indicates that the price action is currently having a very strong trend and therefore can reverse the trend to the average. For this case, the price is above the upper band, and that should mean a near-term correction (at least) until it is under the band
Relative strength index
Broke through the overbought line Wednesday, with a reading of 82.64. Climbing above the overbought zone is not a sell signal, as stock price can be above the level of 70 for many, many weeks and continue to climb
Pfizer stock price history
Pfizer IPO was on Jun 1st, 1972 at $0.00 per share1. Since then, PFE stock has risen by -, with an average of 0.00% per year. An investment of $1,000USD on the IPO would be valued $inf today.
1: Adjusted price after possible price splits or reverse-splits
Price target for Pfizer stock
How much a stock will be priced tomorrow or next week is quite unpredictable. Banks and financial organisations post their analysis predicting how a particular stock will performance in the future.
The following table shows the price forecasts published by analysts in the last 30 days. If you are a small investor you should not invest based on these predictions.
There are 4 price forecasts issued for Pfizer that average $39.50. Pfizer closed at $39.53 on Wednesday, that is a 0.08% than the predicted price.
| Brokerage firm | Price target |
|---|---|
| Mar 23rd, 2021 | |
| Berenberg Bank | $38.00 |
| Mar 26th, 2021 | |
| SVB Leerink | $40.00 → $39.00 |
| Apr 1st, 2021 | |
| SVB Leerink | $40.00 → $39.00 |
| Apr 7th, 2021 | |
| Royal Bank of Canada | $42.00 |
Earnings and financials
Pfizer ($PFE) is hosting the earnings call next Tuesday. Wall Street estimates of $0.78, compared to previous quarter that made $0.42.
Last February, Pfizer ($PFE) had the quarterly earnings call and posted the report. Pfizer posted earnings of $0.42 per share on sales of $11.7 billion. The market estimate was $0.48 per share on revenue of $11.4 billion.
This compares to Earnings of $0.55 per share same quarter last year, so current EPS means a drop of -23.64%. Looking at turnover, figures went down a -7.91% compared to $126.9B same quarter 12 months ago.Pfizer performance
| Company | 1m | 3m | 6m |
|---|---|---|---|
| Pfizer ($PFE) | 10.40% | 9.80% | 12.40% |
Important:
The viewpoints expressed in this post are personal and should not be followed as recommendations for you to buy or sell shares. The author of this text does not know the particular conditions of the reader, his or her own finances or his or her own best interests at any given time. All users should speak with their financial advisor before buying or selling any securities Thoughts are posted for educative motives onlyPfizer summary
| Wednesday, April 21st, 2021 | |
|---|---|
| Open | $39.14 |
| Close | $39.53 |
| Day range | $39.13 - $39.67 |
| Previous close | $39.03 |
| Session gain | 1.28% |
| Average true range | $0.75 |
| 50d mov avg | $35.49 |
| 100d mov avg | $36.36 |
| 200d mov avg | $35.43 |
| Earnings date | April 27th, 2021 |